|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptives, carbohydrate metabolism and diabetes mellitus. |
| [Contraceptifs oraux, metabolisme hydorcarbone et diabete sucre.] |
| Ekoe JM; Vuille C; Albert J |
| Semaine Des Hopitaux. 1983 Dec 8;59(45):3162-6. |
| Disturbances of carbohydrate metabolism due to oral contraceptives (OCs) appear in diabetics but also in |
| nondiabetics, mainly those who are at high risk for diabetes mellitus (advanced age, obesity, family history, previous |
| abnormality of glucose tolerance). Under OCs, diabetes mellitus control deteriorates in 30% of all diabetics. |
| Atherosclerosis seems to be accelerated and can lead to serious cardiovascular complications. Reducing the |
| doses of estrogens and progestogens as well as choosing the least diabetogenic progestogen might help to prevent |
| those complications. We believe that micro- or macro-angiopathy is an absolute contraindication of OCs. |
| (PubHealth.info Document ID: CONT5T 2075-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives, carbohydrate metabolism and diabetes |
| mellitus. [Contraceptifs oraux, metabolisme hydorcarbone et diabete sucre.]", is(are) Ekoe JM; Vuille C; Albert J. |
| The source of this article is "Semaine Des Hopitaux. 1983 Dec 8;59(45):3162-6.". This article was published in 1983 |
| in French language(s). (PubHealth.info® Document ID: CONT5T 2075-06. All rights reserved with PubHealth.info) |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |